RKV — Rakovina Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$8.40m
- CA$9.71m
Annual cashflow statement for Rakovina Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.191 | -5.52 | -2.79 | -2.61 | -4.07 |
| Amortisation | |||||
| Non-Cash Items | 0.106 | 2.95 | 0.259 | 0.173 | 0.19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.017 | -0.145 | 0.08 | 0.042 | -0.51 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.068 | -2.31 | -1.92 | -1.86 | -3.86 |
| Other Investing Cash Flow Items | 0.006 | 0.8 | 0 | — | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.006 | 0.8 | 0 | — | — |
| Financing Cash Flow Items | -0.104 | — | — | -0.113 | -0.188 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.396 | 4.32 | 0.002 | 1.4 | 4.73 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.334 | 2.81 | -1.91 | -0.461 | 0.876 |